115 related articles for article (PubMed ID: 10367130)
1. [Membrane-attacking complexes and membrane complement inhibitors on the leukocyte surface during combined exposure with meningococcus lipopolysaccharide and complement].
Platonov AE; Vershinina IV; Serebrovskaia LV; Shepeleva GK
Biull Eksp Biol Med; 1999 Apr; 127(4):433-8. PubMed ID: 10367130
[No Abstract] [Full Text] [Related]
2. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
3. [Role of membrane molecules in complement system].
Okada N
Rinsho Byori; 1991 Sep; Suppl 91():129-39. PubMed ID: 1721938
[No Abstract] [Full Text] [Related]
4. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
[TBL] [Abstract][Full Text] [Related]
5. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of the complement system.
Makrides SC
Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
[TBL] [Abstract][Full Text] [Related]
7. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
8. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
9. Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.
Hakulinen J; Meri S
Immunology; 1995 Jul; 85(3):495-501. PubMed ID: 7558140
[TBL] [Abstract][Full Text] [Related]
10. Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity.
Yu J; Dong S; Rushmere NK; Morgan BP; Abagyan R; Tomlinson S
Biochemistry; 1997 Aug; 36(31):9423-8. PubMed ID: 9235986
[TBL] [Abstract][Full Text] [Related]
11. Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase.
Nogawa Fonzar-Marana RR; Ferriani RA; Soares SG; Cavalcante-Neto FF; Teixeira JE; Barbosa JE
Fertil Steril; 2006 Sep; 86(3):758-61. PubMed ID: 16831436
[TBL] [Abstract][Full Text] [Related]
12. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
Huang Y; Fedarovich A; Tomlinson S; Davies C
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which the erythrocyte protects itself from complement damage.
Nicholson-Weller A; Halperin JA
Prog Clin Biol Res; 1989; 297():263-70; discussion 270-1. PubMed ID: 2479950
[No Abstract] [Full Text] [Related]
16. The expression of complement regulatory proteins by adult human oligodendrocytes.
Scolding NJ; Morgan BP; Compston DA
J Neuroimmunol; 1998 Apr; 84(1):69-75. PubMed ID: 9600710
[TBL] [Abstract][Full Text] [Related]
17. Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development.
Gancz D; Fishelson Z
Mol Immunol; 2009 Sep; 46(14):2794-800. PubMed ID: 19501402
[TBL] [Abstract][Full Text] [Related]
18. Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines.
Takei K; Yamazaki T; Sawada U; Ishizuka H; Aizawa S
Leuk Res; 2006 May; 30(5):625-31. PubMed ID: 16289746
[TBL] [Abstract][Full Text] [Related]
19. Membrane complement regulatory proteins.
Kim DD; Song WC
Clin Immunol; 2006; 118(2-3):127-36. PubMed ID: 16338172
[TBL] [Abstract][Full Text] [Related]
20. Pathological study on the relationship between C4d, CD59 and C5b-9 in acute renal allograft rejection.
Nishi S; Imai N; Ito Y; Ueno M; Fukase S; Mori H; Arakawa M; Bassam A; Saito K; Takahashi K; Gejyo F
Clin Transplant; 2004; 18 Suppl 11():18-23. PubMed ID: 15191368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]